TheraNews Logo

depression

Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2A Trial Of SPL026 In Major Depressive Disorder

Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2A Trial Of SPL026 In Major Depressive Disorder

February 17, 2026 | menafn

(MENAFN - GlobeNewsWire - Nasdaq) Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive symptoms as ...

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

February 17, 2026 | benzinga

Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRDHEIDELBERG, Germany, Feb. 17, 2026 (GLOBE NEWSWIRE) -- FundaMental Pharma GmbH (or "the Company"), a preclinical-stage biopharmaceutical company focused on developing innovative, dual-acting N-methyl-D-aspartate receptor (NMDAR) modulators aimed at delivering rapid and sustained relief for patients with treatment-resistant depression (TRD), today announces

Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials

Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials

February 17, 2026 | hastingstribune

LONDON & NEW YORK--(BUSINESS WIRE)--Feb 16, 2026--

Eating More Plants Could Help Boost Mood, Focus, and Even Prevent Depression—Here's the Proof

Eating More Plants Could Help Boost Mood, Focus, and Even Prevent Depression—Here's the Proof

February 17, 2026 | vegnews

A plant-based diet can do more than reduce our risk of physical disease. It may improve mood, and even reduce the risk of depression and anxiety, too.

Major Depressive Disorder Shares Immune Abnormalities and Potential Therapeutic Targets With Inflammatory Skin Diseases, According to New Study

Major Depressive Disorder Shares Immune Abnormalities and Potential Therapeutic Targets With Inflammatory Skin Diseases, According to New Study

February 12, 2026 | newswise

Findings provide rationale for targeted strategy in psychiatry that may lead to new personalized treatments for major depressive disorder and other conditions

Biomednewsbreaks - Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Michael Cola As Chief Executive Officer

Biomednewsbreaks - Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Michael Cola As Chief Executive Officer

February 11, 2026 | menafn

(MENAFN - Investor Brand Network)This article has been disseminated on behalf of Helus Pharma and may include paid advertising.Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage ...

Study: Natural protein REELIN could repair leaky gut and alleviate depression

Study: Natural protein REELIN could repair leaky gut and alleviate depression

February 6, 2026 | naturalnews

(NaturalNews) Long dismissed by conventional medicine, leaky gut (intestinal permeability) is now linked to autoimmune disorders, chronic inflammation and depre...

Ballad Health Clinical Director, Behavioral Services weighs in on overcoming seasonal depression

Ballad Health Clinical Director, Behavioral Services weighs in on overcoming seasonal depression

February 5, 2026 | elizabethton

By Brittnee Bryant Star Correspondent Colder days and longer nights can leave individuals feeling depressed during the winter months. It’s a phenomenon known as Seasonal Affective Disorder. According to Cicely [...]

Exercise can be as effective as psychological therapies in treating depression

Exercise can be as effective as psychological therapies in treating depression

February 2, 2026 | naturalnews

(NaturalNews) A major scientific review concludes that physical exercise can be as effective as psychological therapies like cognitive behavioral therapy in all...

PreviousPage 8 of 12Next